|
|
PREDICTING LONG-TERM CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT |
| 1R01CA226080-01A1 |
KESLER, SHELLI R |
NCI |
2019 |
|
|
DEVELOPMENT AND PILOT TESTING OF A HYBRID IN PERSON AND MHEALTH COPING SKILLS TRAINING INTERVENTION FOR SYMPTOM MANAGEMENT AND DAILY STEPS IN STEM CELL TRANSPLANT PATIENTS |
| 1R21CA235083-01 |
KELLEHER, SARAH |
NCI |
2019 |
|
|
WIRELESS TRANSCUTANEOUS ELECTRICAL STIMULATION (TENS) FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A PHASE II RANDOMIZED CLINICAL TRIAL |
| 1R21CA235389-01A1 |
GEWANDTER, JENNIFER |
NCI |
2019 |
|
|
EVALUATION OF MYOCARDIAL TARGETS TO PREVENT ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH DOWN SYNDROME AND LEUKEMIA |
| 1R21CA245067-01 |
BLANCO, JAVIER GUILLERMO |
NCI |
2019 |
|
|
HOME-BASED VIRTUAL REALITY SYSTEM FOR THE TREATMENT OF CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENTS |
| 1R43CA232936-01A1 |
KIM, NAM H. |
NCI |
2019 |
|
|
FIRST AND ONLY SOFT TISSUE SUPPORT DEVICE TO IMPROVE PATIENT EXPERIENCE AND SYSTEM COST IN BREAST RECONSTRUCTION |
| 1R44CA247273-01 |
LOSKEN, ALBERT |
NCI |
2019 |
|
|
INTERFERON SIGNALING AND THE DIFFERENTIAL MALIGNANCY SPECTRUM OF DOWN SYNDROME |
| 3P30CA046934-31S6 |
SCHULICK, RICHARD D |
NCI |
2019 |
|
|
VERY-LONG TERM NEUROCOGNITIVE OUTCOMES IN BREAST CANCER SURVIVORS |
| 3R01CA172145-06S1 |
PALESH, OXANA G |
NCI |
2019 |
|
|
DYRK1A SIGNALING IN CONTROL OF CELL GROWTH, PROLIFERATION AND DNA DAMAGE REPAIR |
| 3R01CA188571-05S1 |
LITOVCHICK, LARISA |
NCI |
2019 |
|
|
THE EFFECT OF COHESIN MUTATIONS IN HEMATOLOGIC MALIGNANCIES |
| 5F31CA216976-03 |
MCNULTY, MAUREEN |
NCI |
2019 |
